Intermediolateral Cell Column Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
| Taxonomy | ID | Name / Label |
|---|
The Intermediolateral Cell Column (IML) is a prominent column of sympathetic preganglionic neurons located in the lateral horn of the spinal cord. These neurons form the central component of the sympathetic nervous system, controlling involuntary functions that maintain homeostasis. The IML is critically important in neurodegenerative diseases, particularly Multiple System Atrophy (MSA), where autonomic failure is a hallmark feature. [1]
The IML extends from the first thoracic segment (T1) to the second lumbar segment (L2), corresponding to the spinal cord segments that give rise to sympathetic outflow to the body. The column is positioned in the lateral horn of the spinal cord gray matter, specifically within lamina VII and portions of lamina IX. [2]
Key anatomical features include: [3]
The IML contains several distinct neuronal populations: [4]
Sympathetic Preganglionic Neurons (SPNs): The primary neuronal type, accounting for approximately 80% of IML neurons
Interneurons: Local circuit neurons that modulate SPN activity
Presympathetic neurons: Neurons that project to sympathetic premotor centers in the brainstem
| Marker | Expression | Significance | [5]
|--------|------------|--------------| [6]
| ChAT | High | Acetylcholine synthesis |
| Phox2b | High | Transcription factor, specifies sympathetic lineage |
| Islet1 | High | Transcription factor |
| Nkx2-2 | Subset | Specification factor |
| NOS | Subset | Nitric oxide synthesis |
| Catecholaminergic enzymes | Subset | Tyrosine hydroxylase expression |
The IML serves as the final common pathway for sympathetic nervous system output, controlling:
Cardiovascular Function
Thermoregulation
Pupillary Function
Visceral Organ Control
The IML receives and integrates multiple input streams:
This integration allows coordinated sympathetic responses to environmental and internal challenges.
MSA is a prototypical neurodegenerative disease affecting the IML:
The selective vulnerability of IML neurons in MSA reflects their unique neurobiological properties:
While primarily affecting dopaminergic neurons, PD involves autonomic dysfunction:
Traumatic or ischemic spinal cord injury above T6 disrupts IML function:
Damage to sympathetic pathways including IML results in:
IML neurons exhibit specific vulnerability factors:
| Drug Class | Target | Application |
|---|---|---|
| Midodrine | α1-adrenergic receptors | Orthostatic hypotension |
| Fludrocortisone | Mineralocorticoid receptors | Volume expansion |
| Pyridostigmine | Cholinesterase | Autonomic function |
| Droxidopa | Norepinephrine precursor | Neurogenic hypotension |
Intermediolateral Cell Column Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Intermediolateral Cell Column Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Benarroch EE. Autonomic nervous system and sleep. Continuum (Minneap Minn). 2015;21(3):690-707. 2015. ↩︎
Wenning GK, Stankovic I, Vignatelli L. Multiple system atrophy: clinicopathological characteristics and neuroimaging. J Neural Transm (Vienna). 2021;128(11):1573-1587. 2021. ↩︎
Kalia LV, Lang AE. Parkinson's disease. Lancet. 2015;386(9996):896-912. 2015. ↩︎
Furlan JC, Fehlings MG. Cardiovascular complications after acute spinal cord injury: pathophysiology, clinical manifestations, and management. J Neurosurg Spine. 2008;8(1):81-92. 2008. ↩︎
Jellinger KA. Neuropathology of multiple system atrophy: new thoughts about pathogenesis. Mov Disord. 2014;29(14):1724-1741. 2014. ↩︎
Benarroch EE. Autonomic failure in neurodegenerative disorders. Semin Neurol. 2007;27(4):330-337. 2007. ↩︎